AUSTRALIAN COMMONWEALTH SCIENTIFIC AND RESEARCH ORGANISATION (CSIRO)
CSIRO contributes integral research and development services to the Vision cooperative Research Centre (VCRC) in both the VCRC's Dynamic Vision-Gel (DV-Gel) and Onlay projects. The outcomes of those projects have since been commercialised by the VCRC through its exclusive license to the new Delaware incorporated spin-out Adventus Technology Inc (Adventus).
CSIRO is a non-core participant in the VCRC, and provides R&D services to it through its Division of Molecular & Health Science Technologies. Formed in 1926 and employing around 6500 staff, CSIRO is Australia's premier research organisation and has a long track-record of breakthrough technologies. CSIRO partners with other parties and uses its multi-disciplinary scientific capability through a variety of models. Its contribution of capability through the VCRC to Adventus Technology is a just one example. With more than 160 existing companies founded on CSIRO technology and many others utilising CSIRO innovations, CSIRO has become one of the largest and most diverse research agencies in the world.
Working in collaboration with the VCRC's outstanding blend of biological and clinical scientists over the last 15 years, CSIRO's participation represents a substantial technical advantage for the DV-Gel and Onlay projects and differentiates the technology underpinning Adventus' opportunity to deliver market-leading ophthalmic products.